Shrina Modi, PA
Medical · Plainsboro, NJNPI 1417425877
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,566 of the $7,853 with a category attached, or 70.9%. 29 manufacturers reported payments, led by Ardelyx, Inc. at 31.4% of the total. 2025 is the largest year on record at $3,511, more than ten times the $314 reported in 2021. Among medical clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 290 payments — averaging $27.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ardelyx, Inc.$2K
- AbbVie$2K
- Johnson & Johnson$614
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$524
- Sanofi$324
- Ironwood Pharmaceuticals, Inc$234
- plus $2K from 23 others
What the payments were for
- Speaking & faculty fees$2,12527%
- Food & beverage$5,56671%
- Education$1622%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ardelyx, Inc. | 18 | $2,464 |
| AbbVie | 81 | $1,656 |
| Johnson & Johnson | 28 | $614 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 36 | $524 |
| Sanofi | 17 | $324 |
| Ironwood Pharmaceuticals, Inc | 12 | $234 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $228 |
| Pfizer | 12 | $199 |
| Ferring Pharmaceuticals Inc. | 9 | $155 |
| Madrigal Pharmaceuticals | 8 | $144 |
| Phathom Pharmaceuticals, Inc. | 11 | $140 |
| Globus Medical | 1 | $137 |
| Regeneron Healthcare Solutions, Inc. | 2 | $134 |
| Axonics, Inc. | 1 | $119 |
| Janssen Scientific Affairs, LLC | 1 | $101 |
| Lilly USA, LLC | 5 | $99 |
| Aimmune Therapeutics, Inc. | 5 | $87 |
| Nestle Healthcare Nutrition Inc. | 5 | $71 |
| Braintree Laboratories, Inc. | 4 | $63 |
| Intercept Pharmaceuticals, Inc. | 4 | $63 |
| Bristol Myers Squibb | 4 | $61 |
| Ipsen Biopharmaceuticals, Inc | 3 | $59 |
| Exact Sciences | 3 | $55 |
| Fresenius Kabi USA, LLC | 2 | $32 |
| Novo Nordisk | 2 | $31 |
| Celltrion USA Inc. | 1 | $17 |
| Redhill Biopharma Inc. | 1 | $15 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
| Sandoz | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,853 in reported general payments places this provider in the 95th percentile of 573 medical providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 19 | $24,150 |
| CreonLipase/Protease/Amylase | 11 | $13,867 |
| Mesalamine | 16 | $5,886 |
| Sucralfate | 19 | $4,200 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 11 | $1,896 |
| CholestyramineCholestyramine (With Sugar) | 15 | $988 |
| Pantoprazole Sodium | 71 | $889 |
| Omeprazole | 82 | $841 |
| Famotidine | 46 | $704 |
| Esomeprazole Magnesium | 21 | $403 |
| Dicyclomine Hcl | 14 | $227 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Creon | $1,656 | $38,01730 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $155 | $1,89611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 573 medical providers in New Jersey.
Other medical in Plainsboro
- Shannon WelnerVerona$176K
- Christinna DelgenioColts Neck$114K
- Anita FoxVerona$17K
- Therese CasasKinnelon$16K
- Joseph CollettiLinwood$16K
- Melissa MiaoKearny$14K
- Gabriela Plesek-AndiaVerona$13K
- Stephanie PhillipsMarlton$12K
- Sean AdairCape May Court House$12K
- Shane CourtneyLinwood$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.